共 50 条
- [1] EXPLORING TIMELINES FOR NEW MEDICINES REIMBURSED IN IRELAND IN 2021 [J]. VALUE IN HEALTH, 2022, 25 (12) : S262 - S262
- [2] HTA AND REIMBURSEMENT TIMELINES IN THE REPUBLIC OF IRELAND [J]. VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
- [4] INSIGHTS INTO REIMBURSEMENT RATES AND TIMELINES FOR ORPHAN DRUGS IN IRELAND [J]. VALUE IN HEALTH, 2019, 22 : S726 - S726
- [8] Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
- [9] Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland [J]. Irish Journal of Medical Science (1971 -), 2023, 192 : 541 - 548